Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gordon Dunn currently holds 122,221 shares of Quoin Pharmaceuticals, Ltd. (QNRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gordon Dunn has been a net buyer of QNRX stock. They have purchased $23.2K and sold $0 worth of shares.
Gordon Dunn's most recent insider trade was on Dec 23, 2024, when they purchased 122,221 shares at $0.00 per share.
Gordon Dunn serves as Executive at Quoin Pharmaceuticals, Ltd. (QNRX). They have executed 8 insider transactions totaling $23.2K over their tenure at the company.
Gordon Dunn holds the position of Executive at Quoin Pharmaceuticals, Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Gordon Dunn has shown a buying trading pattern, with $23.2K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Gordon Dunn was on Sep 10, 2024, when they purchased $9.1K worth of QNRX shares. This transaction involved 10,000 shares at $0.91 per share.
Gordon Dunn currently owns 122,221 shares of Quoin Pharmaceuticals, Ltd. (QNRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gordon Dunn's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gordon Dunn has 8 Form 4 filings on record as an insider at Quoin Pharmaceuticals, Ltd..
Set alerts for Gordon Dunn and 40,000+ other insiders.